Enanta Pharmaceuticals (ENTA) Interest Expenses (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded Interest Expenses of $4.13 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 155.3% from $1.62 million a year earlier and up 24.5% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Interest Expenses (2012 - 2026) Analysis & Trends
On a TTM basis, Enanta Pharmaceuticals' Interest Expenses came in at $12.92 million as of Jun 30, 2026, up 64.0% year-over-year; for FY2025 (ended Sep 30, 2025), it was $7.68 million, down 29.8% from FY2024.
- Across earlier fiscal years, Interest Expenses came in at $10.94 million in FY2024 (+112.5%) and $5.15 million in FY2023.
- The fiscal Q3 2026 figure is the highest quarterly Interest Expenses in data going back to fiscal Q1 2013.
- On a year-over-year basis, Interest Expenses has increased for three consecutive quarters, with growth averaging 21.6% over the last eight quarters.
- Peak year-over-year performance for Interest Expenses in the last five years was growth of 155.3% in fiscal Q3 2026, against a decline of 43.0% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $3.32 million (Q2 2026), $3.08 million (Q1 2026) and $2.39 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - | 4.13 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.13 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 9,000.00 |
| Jun 30, 2017 | 11,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 11,000.00 |
| Jun 30, 2016 | 11,000.00 |
Enanta Pharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();